DSIP (delta sleep-inducing peptide) is a naturally occurring nonapeptide (sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, molecular weight ~849) first isolated from the cerebral venous blood of rabbits during induced sleep, and studied in laboratory models for its association with delta-wave (slow-wave) sleep and a range of neuromodulatory and stress-related processes. It is used strictly as a research reference compound for investigating central-nervous-system signaling, thermoregulation, and oxidative balance in in-vitro and animal-model systems. As of 2026, its precise receptor target remains uncharacterized, and it continues to be described in the literature as an unresolved but actively studied peptide.
Research Background
DSIP was first identified in the 1970s through experiments in which blood from sleep-induced rabbits appeared to transfer sleep-associated activity to recipient animals, leading to isolation of the peptide responsible. Early characterization is summarized in a foundational review of the peptide (Delta-sleep-inducing peptide (DSIP): a review). In laboratory studies, DSIP has been reported to promote delta (slow-wave) sleep patterns in rabbits, rats, mice, and other species, while in cats effects on REM sleep were comparatively more pronounced — an example of the species-dependent responses researchers must account for in experimental design.
Despite decades of investigation, DSIP has no single, confirmed receptor, and its endogenous role is not fully defined. A widely cited review frames this ambiguity directly, describing the peptide as a "still unresolved riddle" whose distribution, degradation, and signaling continue to be studied. This makes DSIP a useful tool compound for probing how a small, endogenous peptide can exert broad, context-dependent effects across neurochemical systems.
Mechanism of Action
The mechanisms attributed to DSIP in research models are multiple and overlapping rather than reducible to a single pathway. Reported findings in the literature include:
Neurotransmitter interactions
In rodent models, DSIP has been studied for interactions with several neurotransmitter systems. Its thermoregulatory effects have been linked to serotonergic (5-HT1A) signaling, while antinociceptive effects observed in spinal models were antagonized by alpha-adrenergic and alpha-2-adrenergic blockers rather than serotonin antagonists, implicating a noradrenergic mechanism. Separately, DSIP has been reported to inhibit somatostatin (SRIF) release through a dopaminergic mechanism. Together these observations suggest DSIP acts as a modulator that interfaces with multiple monoaminergic systems depending on the tissue and experimental context.Blood-brain barrier transport
Studies in perfused brain preparations described a high-affinity, saturable transport mechanism for DSIP at the blood-brain barrier, indicating specific carrier-mediated movement rather than simple diffusion — a relevant consideration for researchers modeling central versus peripheral effects.Oxidative-balance and stress models
A recurring research theme examines DSIP in relation to oxidative stress. In rodent cold-stress and foot-shock-stress models, DSIP administration was associated with increased activity of antioxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase, and glutathione reductase, and with normalization of lipid-peroxidation markers such as malondialdehyde (MDA). Some DSIP analogues have shown direct antioxidative activity in vitro. These findings position DSIP as a compound of interest in laboratory investigations of the prooxidant-antioxidant balance under stress.Published Research Overview
Research involving DSIP spans several recurring areas in laboratory settings. The most historically prominent is sleep and electrophysiology, where the peptide's association with delta-wave activity has been examined in multiple species. A second area is thermoregulation and neuroendocrine signaling, including effects on core temperature and hormone release. A third is stress physiology and oxidative balance, as summarized above.
More recent work has kept the peptide in active study. A 2021 study reported that DSIP administration was associated with recovery of motor function in a rat focal-stroke model (Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke). A 2024 investigation used a DSIP fusion-peptide construct in a PCPA-induced insomnia mouse model to study blood-brain-barrier crossing and sleep-related activity, reflecting continued methodological interest in delivery and mechanism. These studies are laboratory and animal-model investigations; they do not establish human applications.
Storage & Handling
DSIP (99%+) is typically supplied as a lyophilized (freeze-dried) powder. For optimal preservation, store the lyophilized peptide at -20°C, protected from light and moisture. Reconstitute immediately prior to use with sterile water or a suitable buffer such as phosphate-buffered saline (PBS), following established laboratory protocols. Because small peptides are sensitive to degradation, avoid repeated freeze-thaw cycles, which can compromise integrity. Reconstituted material is generally stored at 2-8°C for short-term use and aliquoted for longer-term storage to minimize freeze-thaw exposure.
Conclusion
DSIP remains an actively studied yet incompletely understood endogenous nonapeptide. Its associations with delta-wave sleep, monoaminergic signaling, thermoregulation, and antioxidant enzyme activity make it broadly relevant to neuroscience and stress-physiology research, even as its definitive receptor and endogenous function stay unresolved. This product is for research use only and is not intended for human or animal consumption, diagnostic, or therapeutic use.
Frequently Asked Questions
What kind of molecule is DSIP?
DSIP is a nonapeptide — a chain of nine amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) with a molecular weight of approximately 849. It was originally isolated from the venous blood of sleep-induced rabbits and is studied as an endogenous neuromodulatory peptide.
Does DSIP have a known receptor?
No single confirmed receptor has been identified. Reviews continue to describe DSIP as unresolved, and its effects appear to be mediated indirectly through interactions with serotonergic, noradrenergic, and dopaminergic systems in a context-dependent manner.
Why is DSIP studied in oxidative-stress models?
In rodent stress models, DSIP has been associated with increased antioxidant enzyme activity (SOD, catalase, glutathione peroxidase) and normalization of lipid-peroxidation markers, making it a compound of interest for laboratory research on the prooxidant-antioxidant balance.
What solvent is used to reconstitute DSIP?
DSIP is generally reconstituted with sterile water or a compatible buffer such as PBS, following established laboratory protocols. The choice may depend on the assay and compatibility with other reagents.